Purchase 4-HO-MET
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 4-HO-MET for sale
4-HO-MET is a lesser-known psychedelic drug. It is a structural− and functional analog of psilocin and the 4-hydroxyl analog of methyl ethyl tryptamine (MET). Alexander Shulgin first synthesized 4-HO-MET.
4-HO-MET (4-hydroxy-N-methyl-N-dimethyltryptamine, melatonin, or methylcybin) is a lesser-known psychedelic drug. It is a structural− and functional analog of psilocin and the 4-hydroxyl analog of methyl ethyl tryptamine (MET).
Produces psychedelic effects when administered. Similar to LSD. Caution should be used with this substance.
This powerful psychedelic can cause psychotropic activity with a dosage as small as 0.2mg.
4-HO-MET (4-hydroxy-N-methyl-N-dimethyltryptamine, melatonin, or methylcybin) is a lesser-known psychedelic drug. It is a structural and functional analog of psilocin and the 4-hydroxyl analog of methyl ethyl tryptamine (MET).
4-HO-MET (4-hydroxy-N-methyl-N-dimethyltryptamine) is a lesser-known psychedelic drug that has been sold as a designer drug. It has structural similarities to the classical hallucinogen psilocin and the tryptamine derivative 4-HO-DMT (Psilacetin).
4-HO-MET (4-hydroxy-N-methyl-N-dimethyltryptamine) is a lesser-known psychedelic drug sold as a designer drug, often confused with psilocin.
4-HO-MET, or 4-hydroxy-N-methyl-N-dimethyltryptamine, is a lesser-known psychedelic. It has structural similarities to psilocin and the tryptamine derivative 4-HO-DMT.
4-HO-MET is largely unknown and has been sold as a designer drug. It has a close resemblance to psilocin, as well as the tryptamine derivative 4-HO-DMT (Psilacetin).
4-HO-MET (4-hydroxy-N-methyl-N-dimethyltryptamine) has structural similarities to classical psilocin and 4-HO-DMT.
4-HO-MET is a psychedelic drug that has the chemical formula C12H17N3O4. It acts on serotonin receptor agonistic effects in humans.
4-HO-met produces hallucinogenic effects similar to the more commonly available psilocin and psilocybin.
4-HO-MET is a psilocybin analog that has been used as an alternative to psilocybin mushrooms by some people seeking a legal high. It is commonly found in powder or capsule form, but it can also be sold as a liquid solution sprayed on cannabis. The substance can have psychedelic effects when consumed, and overdoses have resulted in death from respiratory failure.
4-HO-MET is a synthetic chemical substance most commonly found in powder or capsule form, but it can also be sold as a liquid solution sprayed onto cannabis. The product contains psychedelic properties that can be harmful to the human body when consumed excessively.
4-HO-MET (also known as 4‑hydroxy -N-methyl--tryptamine) is a psychedelic hallucinogenic drug that acts as a serotonin agonist. It was first detected in the 1960s and was popular among some members of the hippie counterculture. While it remains technically legal in some areas, the US Drug Enforcement Administration reported increasing arrests for possessing psilocybin mushrooms between 2005 and 2006. The substance's side effects can include increased heart rate and respiratory issues, leading to death by overdose.
4-HO-MET is a new psychoactive substance with psychological effects similar to LSD. It is currently sold legally and illegally as a research chemical.
4-HO-MET is an illegal psychedelic substance that is similar in structure to psilocybin.
4-Ho-MET is a synthetic psychedelic substance of the lysergamide class. It is considered an analog of psilocin, which means it is similar in its activity to psilocin (4-HO-DMT). 4-Ho-MET breaks down into 4-HO-DMT when digested, and it can take more than a day for these substances to be completely excreted by the body.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
100g $390
1kg $2400
500g $1199
100g $600
100g $500
500g $1080
200g $690
100g $550
1kg $1690
100g $390
500g $1390